CLINICAL_TRIALS
trial_result
· 2024-09-19
Clinical Trial Update: PVSRIPO for Patients With Unresectable Melanoma [Phase 1]
Summary
Phase 1 trial of PVSRIPO for unresectable melanoma has been terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Istari Oncology, Inc. | Conditions: Melanoma | Phase 1 | Status: TERMINATED | Results posted: 2024-09-19